Sassi Nir 4
4 · Indaptus Therapeutics, Inc. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-18+40,000→ 40,000 totalExercise: $1.61Exp: 2033-01-18→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026.